Figure 2. Kaplan–Meier estimation of cumulative proportion of no tumor recurrence.
A: loss of E-cadherin membranous (E-cad-) expression, B: Loss of β-catenin membranous (β-catM-) expression, C: loss of E-cadherin and β-catenin membranous (E-cad−/β-cat M-) expression, D: ALCAM cytoplasmic positive and E-cadherin membrane loss (E-cad−/ALCAM C+).